文献速递小儿神经外科与脑积水神经肿瘤

内镜下第三脑室造瘘术:前入路手术结局分析

Endoscopic Third Ventriculostomy: Outcome Analysis of an Anterior Entry Point.
PubMed 文献 · World Neurosurg · 2017-05-19

本研究评估本中心20年来常规使用的、位于冠状缝前4 cm、Kocher点前3 cm、中瞳孔线距瞳孔约9 cm的前入路行内镜下第三脑室造瘘术(ETV)的安全性与有效性。共纳入131例患者,ETV成功125例(95.4%),26例(19.8%)需活检,其中21例(80.8%)成功,10例(7.6%)出现并发症,ETV成功率与年龄(P=0.5)或性别(P=0.99)无关。作者认为前入路是安全有效的ETV方法,尤其考虑同期脑室肿瘤活检时,使用硬性内镜时可考虑为更微创的操作,并可能免去软性内镜的需要。

要点

  • 前入路ETV成功125/131例(95.4%),并发症10例(7.6%)。
  • 26例(19.8%)需活检,其中21例(80.8%)成功。
  • ETV成功率与年龄(P=0.5)或性别(P=0.99)无关。

核心结论

  • 前入路是ETV安全有效的方法,尤其考虑同期脑室肿瘤活检时。
  • 使用硬性内镜时,该入路可考虑为更微创的操作,并可能免去软性内镜的需要。

研究设计与样本

  • 本研究为单中心研究,评估本中心过去20年常规使用的前入路行ETV(伴或不伴同期内镜活检)的安全性与有效性。
  • 共纳入131例采用该前入路的患者,通过回归分析评估年龄、性别、脑积水病因、肿瘤位置与病理及并发症率对肿瘤活检和ETV成功率及后续脑室分流需求的影响。

主要发现

  • ETV成功125例(95.4%)。
  • 26例(19.8%)患者需活检,其中21例(80.8%)成功。
  • 10例(7.6%)患者出现并发症,并发症有在ETV失败后发生的趋势。
  • ETV成功率与患者年龄(P=0.5)或性别(P=0.99)无关。

临床怎么用

  • 作者认为前入路是ETV安全有效的方法,尤其考虑同期脑室肿瘤活检时。
  • 作者认为使用硬性内镜时,该入路可考虑为更微创的操作,并可能免去软性内镜的需要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic third ventriculostomy (ETV) is a safe and effective treatment for hydrocephalus. An entry point located 4 cm anterior to the coronal suture, 3 cm anterior to Kocher point, and approximately 9 cm from the pupil at the midpupillary line has been used successfully for the last 20 years in our center. We aimed to evaluate this alternative anterior entry point routinely used for ETV, with or without concurrent endoscopic biopsy. METHODS: Patients undergoing this proposed entry point were examined to evaluate its safety and efficacy. Factors such as patients' age, sex, hydrocephalus etiology, tumor location and pathology, and complication rate were examined through regression analyses to evaluate their impact on tumor biopsy and ETV success rates, and the need for subsequent ventricular shunting. RESULTS: A total of 131 patients were included in the study. ETV was successful in 125 (95.4%) patients. Of these, 26 (19.8%) patients required a biopsy, which was successful in 21 (80.8%) cases. A complication was observed in 10 (7.6%) patients, with a trend toward complications occurring after ETV failure. There was no association between ETV success rate and patients' age (P = 0.5) or sex (P = 0.99). CONCLUSIONS: The anterior entry point is a safe and effective method for ETV, especially when considering concurrent ventricular tumor biopsy. This entry point may be considered as a more minimally invasive procedure when using rigid endoscopy and may also eliminate the need for a flexible scope.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Aref M, Martyniuk A, Nath S, et al. Endoscopic Third Ventriculostomy: Outcome Analysis of an Anterior Entry Point. World Neurosurg. 2017. PMID: 28532915. doi:10.1016/j.wneu.2017.05.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。